WCN'24 Transplant-Onconephrology

This session highlights the complex field of renal transplantation and it's intersection with oncology. This session will update the audience with use of immunotherapy in organ transplant patients and use of liquid biopsies in cancer diagnosis along with latest updates in using kidneys with renal tumors in transplantation.

Naoka Murakami

USA

Germaine Wong

Australia

Germaine Wong is an academic transplant nephrologist at Westmead Hospital, in Sydney. She is the Director of the Western Renal Service, Western Sydney Local Health District. She is also a Principal Research Fellow at the University of Sydney. Her main areas of interest are cancer epidemiology, diagnostic test evaluations, decision and simulation modelling, and other important aspects of outcomes research in nephrology and transplantation such as utility-based quality of life measures, transplantation outcomes in young adults, cancer and cardiovascular disease after transplantation; and areas in organ donation, wait-listing and organ allocation. She has expertise in diagnostic test evaluation methodologies, biostatistics, simulation modelling, and has examined topics including the cost-effectiveness of cancer screening and other pharmaceutical interventions in patients on dialysis and with kidney transplants.

Key:

Complete
Failed
Available
Locked
Use of Immunotherapy in Patients With Organ Transplants
Open to view video.
Open to view video.
You must register to access.
Transplantation Outcomes in Recipients with History of Cancer
Open to view video.
Open to view video.
You must register to access.
Use of AI in Transplant Onconephrology
Open to view video.
Open to view video.
You must register to access.